These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 31966487)
1. Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in bladder cancer. Guan HJ; Li XX; Guo YP; Dong J; Rong SZ; Niu YY; Meng LL; Zhao FY; Fan XJ; Zhang YS; Yang YD; Nan XH; Qi BL Int J Clin Exp Pathol; 2017; 10(11):11326-11334. PubMed ID: 31966487 [TBL] [Abstract][Full Text] [Related]
2. Aberrant Methylation of Suppressor of Cytokine Signaling 1 (SOCS1) Gene as a Biomarker for Early Prediction and Diagnosis of Bladder Cancer. Guan H; Li X; Lu J; Meng L; Guo Y; Dong J; Rong S; Zhao F; Shen H Clin Lab; 2020 May; 66(5):. PubMed ID: 32390384 [TBL] [Abstract][Full Text] [Related]
3. Promoter methylation and expression of SOCS3 affect the clinical outcome of pediatric acute lymphoblastic leukemia by JAK/STAT pathway. Liu K; Wu Z; Chu J; Yang L; Wang N Biomed Pharmacother; 2019 Jul; 115():108913. PubMed ID: 31054507 [TBL] [Abstract][Full Text] [Related]
4. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells. Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296 [TBL] [Abstract][Full Text] [Related]
5. SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation. Lindemann C; Hackmann O; Delic S; Schmidt N; Reifenberger G; Riemenschneider MJ Acta Neuropathol; 2011 Aug; 122(2):241-51. PubMed ID: 21590492 [TBL] [Abstract][Full Text] [Related]
6. SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma. Zhang X; You Q; Zhang X; Chen X Int J Mol Sci; 2015 Sep; 16(9):22662-75. PubMed ID: 26393582 [TBL] [Abstract][Full Text] [Related]
7. Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma. Wilop S; van Gemmeren TB; Lentjes MH; van Engeland M; Herman JG; Brümmendorf TH; Jost E; Galm O Epigenetics; 2011 Aug; 6(8):1047-52. PubMed ID: 21934357 [TBL] [Abstract][Full Text] [Related]
8. Association between the methylation of CpG islands in JAK-STAT pathway-related genes and colorectal cancer. Rong J; Pu R; Sun H; Liu Y; Tian T; Bi H; Xia T; Zhang L; Zhang Y; Zhao Y; Zhu L Gene; 2023 Jun; 868():147357. PubMed ID: 36914143 [TBL] [Abstract][Full Text] [Related]
9. Methylation status of the SOCS3 gene in human malignant melanomas. Tokita T; Maesawa C; Kimura T; Kotani K; Takahashi K; Akasaka T; Masuda T Int J Oncol; 2007 Mar; 30(3):689-94. PubMed ID: 17273770 [TBL] [Abstract][Full Text] [Related]
10. DNMTs-mediated SOCS3 methylation promotes the occurrence and development of AML. Zhang X; Zhang K; Zhang J; Chang W; Zhao Y; Suo X Eur J Haematol; 2024 Mar; 112(3):439-449. PubMed ID: 37950514 [TBL] [Abstract][Full Text] [Related]
11. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms. Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of SOCS3 and its biological function in colorectal cancer. Chu Q; Shen D; He L; Wang H; Liu C; Zhang W Gene; 2017 Sep; 627():114-122. PubMed ID: 28603075 [TBL] [Abstract][Full Text] [Related]
13. Methylation Pattern of the SOCS3 and IL6R Promoters in Rheumatoid Arthritis. Cieśla M; Kolarz B; Majdan M; Darmochwał-Kolarz D Int J Inflam; 2020; 2020():8394659. PubMed ID: 32292581 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells. Barclay JL; Anderson ST; Waters MJ; Curlewis JD Mol Endocrinol; 2007 Oct; 21(10):2516-28. PubMed ID: 17636039 [TBL] [Abstract][Full Text] [Related]
15. Methylation of SOCS3 in Myeloproliferative Neoplasms and Secondary Erythrocytosis/Thrombocythemia. Torun D; Nevruz O; Akyol M; Kozan S; Bahçe M; Güran S; Beyan C Turk J Haematol; 2013 Mar; 30(1):13-8. PubMed ID: 24385747 [TBL] [Abstract][Full Text] [Related]
16. JAK2, STAT3 and SOCS3 gene expression in women with and without breast cancer. Santillán-Benítez JG; Mendieta-Zerón H; Gómez-Oliván LM; Ordóñez Quiroz A; Torres-Juárez JJ; González-Bañales JM Gene; 2014 Aug; 547(1):70-6. PubMed ID: 24932998 [TBL] [Abstract][Full Text] [Related]
17. IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain. Zhang L; Badgwell DB; Bevers JJ; Schlessinger K; Murray PJ; Levy DE; Watowich SS Mol Cell Biochem; 2006 Aug; 288(1-2):179-89. PubMed ID: 16718380 [TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells. Lin YC; Lin CK; Tsai YH; Weng HH; Li YC; You L; Chen JK; Jablons DM; Yang CT Oncol Rep; 2010 Dec; 24(6):1605-12. PubMed ID: 21042758 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic beta-cells. Laubner K; Kieffer TJ; Lam NT; Niu X; Jakob F; Seufert J Diabetes; 2005 Dec; 54(12):3410-7. PubMed ID: 16306356 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders. Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]